Original Paper
Abstract
Background: Mobile health tools that use the Experience Sampling Method (ESM) appear to be a promising tool to streamline and improve the treatment of substance use disorders. However, patient involvement in the development of these tools is uncommon, and research on the preferences of people being treated for substance use disorders has been scarce. In the scope of the European Union IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) consortium, an ESM-based tool for Digital Mobile Mental Health (DMMH) was first codeveloped and later tested in 4 European countries.
Objective: This study aimed to achieve an understanding of preferences for features of DMMH among mental health service users with problem substance use.
Methods: In 4 European countries, service users were recruited for a semistructured qualitative interview, which started with the presentation of a prototype of the DMMH. Data analysis was performed through directed qualitative content analysis.
Results: The analytical sample consisted of 12 (5 female, 6 male, and 1 nonbinary person) participants with problem substance use aged 18-50 years. There were 4 participants from Slovakia, 3 from Belgium, 4 from Germany, and 1 from Scotland. Patient preferences were classified into 7 categories: notifications, questions, user interface, functionality changes, visualizations, sharing data with clinicians, and sharing data with others. The proposed intensive notification schedule was deemed acceptable by service users as long as the questionnaire is short. Participants expressed a preference for open-text response options, Ecological Momentary Interventions, and options for individual customization of several elements of the tool. Data visualization was considered an important aid for communication with clinicians, with whom all participants wanted to share data obtained with DMMH. The possibility of sharing data with other people depended on the quality of the relationship with them.
Conclusions: In the development of ESM-based mobile health tools for people with problem substance use, their preferences for content, functionality, and appearance of the tools should be considered so they match patients’ treatment needs.
doi:10.2196/79510
Keywords
Introduction
Mobile health (mHealth) tools based on Experience Sampling Method (ESM) appear to be a promising element in delivering more person-centered mental health care [-]. mHealth is a public health practice supported by mobile devices such as mobile phones, tablets, portable patient monitoring devices, personal digital assistants, and other wireless devices []. ESM is a data acquisition process characterized by repeatedly sampling participants’ actual behaviors and experiences in real time in their natural environment []. The goal of ESM is to minimize the memory biases that arise from retrospective assessment of experience and mental states, to maximize ecological validity, and to enable capturing microprocesses that influence behavior in real-world contexts []. The use of ESM as part of a treatment appears to be a promising avenue toward personalized, person-centered mental health care []. It can help patients better understand their adaptive and maladaptive behavior patterns and the reasons behind them. Providing patients with these tools allows them to become more active partners in the treatment process [].
In the treatment of substance use disorders (SUDs), in addition to the aforementioned benefits, ESM can make a significant contribution to the early detection of impending relapse [] and provide a reliable basis for individually tailored interventions based on the dynamic changes during the treatment []. Treatments provided in mental health settings are often ineffective for patients with SUDs [], which may be related to the fact that treatment of SUDs and comorbid disorders requires high intensity and emphasis on psychosocial interventions []. Relapse is preceded by craving, the intensity of which fluctuates dynamically and is often triggered by external and internal factors. ESM is a good tool to catch it early [,,]. Although we have limited evidence on the efficacy of mHealth tools in the treatment of SUDs [], some methodologically rigorous studies have produced results on their effectiveness and usefulness in increasing the number of abstinence days both during treatment and in follow-up [-]. A challenge to the effective application of mHealth tools in the treatment of individuals with SUDs is to explore how to successfully implement them into clinical practice. Successful and sustainable implementation of new digital health technologies is challenging and depends on a variety of factors, including patient acceptance and expectations regarding the adoption and use of these tools []. The feasibility and acceptability of using digital instruments with embedded ESM in the treatment of SUDs appear to be high [-], and this is also true for tools with intensive data collection schedules [,]. However, low uptake and limited user engagement are common challenges observed in digital interventions within real-world care settings [].
A systematic review conducted by Szinay et al [] identified 3 categories of factors that influence the uptake and effective engagement in the use of mHealth tools: capability-enhancing factors, opportunity-enhancing factors, and motivation-enhancing factors. The first category relates to app literacy skills, app awareness, available user guidance, health information, statistical information on progress, well-designed reminders, features to reduce cognitive load, and self-monitoring features. The second category includes factors such as availability at low cost, positive tone, personalization factors, recommendations for health and well-being, embedded health professional support, and social networking opportunities. Finally, the third category entails factors such as positive feedback, available rewards, goal setting, and the perceived utility of the tool. Another important factor influencing the uptake and effective engagement with digital tools is their appropriateness for the intended users and the context in which they are to be implemented. Tools are more likely to be adopted when they are personally relevant and can be seamlessly integrated into users’ daily routines []. A common reason for poor fit is the insufficient involvement of patients, stakeholders, and other end users in the development process. Stakeholders are typically engaged only in the final stages of development, such as during usability testing, when the opportunity to make substantive changes is limited [,]. Early and continuous involvement of stakeholders is essential to ensure that digital tools are aligned with real-world needs, thereby facilitating more effective implementation []. Qualitative research methods are central to understanding how to improve user uptake and engagement with mHealth tools [].
Previous research on potential users of mHealth tools with SUDs has shown that positivity, personalization, monitoring of use, gaining insight into use, daily tips, and interactive features are considered facilitators of the use of mHealth tools. On the other hand, repetitiveness, receipt of nontailored content, and inability to self-navigate to desired content are considered barriers to the use of mHealth tools by individuals with SUDs [,,]. Daily notifications can substantially impact the engagement of individuals in both positive and negative ways. Optimizing the notification policy to target both effectiveness and engagement is needed []. Although the general facilitators and barriers of mHealth tools for persons with SUDs are known, it is unclear whether and how these patterns manifest in a population with more complex needs, such as people with comorbid mental disorders.
Therefore, this study aimed to achieve a better and more detailed understanding of the preferences of mental health service users with problem substance use regarding the features of an ESM-based digital tool. More specifically, we aimed to explore what patients with problem substance use consider to be a satisfactory design (content, appearance, and functionality) of an ESM-based mHealth tool that they would use as part of their treatment.
Methods
Study Design and Research Paradigm
This study used a qualitative design using semistructured interviews, guided by an interpretivist-pragmatic paradigm [], combining the interpretive understanding of participants’ experiences with a pragmatic focus on the applicability of findings to clinical practice. Semistructured interviews were designed to collect information about relevant contextual factors within the Non-Adoption, Abandonment, Scale-Up, Spread, and Sustainability (NASSS) framework [] related to the potential use of the Digital Mobile Mental Health tool (DMMH) as a part of the IMMERSE (Implementing Mobile Mental health Recording Strategy for Europe) project [].
Setting and Context
The study was carried out in the context of the ongoing IMMERSE project. The IMMERSE project is dedicated to advancing person-centered mental health care through the development and implementation of the DMMH [,].
The DMMH consists of two components: (1) MoMent app (movisens GmbH) for patients, an ESM-based digital mobile app for systematic monitoring of patients’ current mental state, mood, symptoms, activities, context, therapy goals, key problem areas, and momentary quality of life; and (2) a dashboard that allows clinicians to (a) customize individual treatment goals and questionnaires presented by the MoMent app and (b) produce automated reports that provide meaningful information from self-assessment data using the integrated dashboard, which is an interface to visualize and elaborate the collected data into customized feedback for patients and their clinician.
This paper reports on findings from Phase I of IMMERSE, where qualitative, semistructured interviews were conducted prior to the development of the DMMH tool and its implementation (Phase II). The aim of Phase I of the project was to develop, optimize, and examine in detail the contextual factors, processes, and strategies for the implementation of the DMMH intervention in routine mental health care in 4 European countries (Belgium, Germany, Scotland, and Slovakia). It involved conducting semistructured interviews with 4 groups of stakeholders, namely service users, clinicians, people from the service user support network, and health care administrators.
In this study, we focus on service users with problem substance use. In other groups of stakeholders, relatives of service users with problem substance use, clinicians specializing in this group of patients, and health care administrators for people with SUDs were underrepresented, so we do not focus on these groups of stakeholders.
Participants for the study were recruited from multiple clinical sites across participating countries. The target sample sizes for the interview component were 40 service users (10 per country). These were users of psychiatric services in outpatient and inpatient care. Clinical sites were located in Belgium (KU Leuven University Hospital and Psychiatric Center Sint-Kamillus, Bierbeek), Germany (Central Institute of Mental Health Mannheim and Psychiatric Centre Nordbaden Wiesloch), Slovakia (Psychiatric Clinic at University Hospital Bratislava plus outpatient clinics in Vranov nad Topľou/Hanušovce/Košice), and Scotland (NHS Lothian, including Lothian CAMHS).
Participants and Sampling
Participants were recruited using purposive sampling to ensure diversity of perspectives across treatment settings. Inclusion was based on predefined eligibility criteria relevant to the study’s aims.
Inclusion criteria for service users were (1) aged 18-64 years, (2) seeking help for mental health issues and needing specialist assessment, (3) in contact with or awaiting local mental health services, and (4) able to give informed consent. Exclusion criteria were (1) psychiatric symptoms due to an organic cause (ICD-10 [International Classification of Diseases, Tenth Revision] F00-F09), (2) intellectual disability or severe psychiatric disorder (ICD-10 F71-F89) impairing consent ability, (3) medical or psychological contraindications, inability to use a smartphone, insufficient language, or terminal illness. Given the aims of this study, we focused on service users who were problem users of psychoactive substances, that is, those who had a SUD or whose substance use caused them significant problems in their lives. Participants meeting the narrower criteria for inclusion in this paper were retrieved from the interview transcripts using the following search terms: “drugs,” “alcohol,” and “addiction.” The identified transcripts were reviewed to determine whether the participants met the stated criteria.
Recruitment Procedure
Recruitment was conducted through a combination of strategies tailored to each site. At the Belgian sites, recruitment lasted approximately 4 months (late January 2022-late May 2022), using flyers, posters, email invitations, and contacting previous participants from related studies and patient organizations. At the German sites, recruitment spanned 6 months (late January 2022-late June 2022) and used clinical site contact, patient organizations, email invites, and on-site presentations. For the Slovak sites, recruitment lasted from December 2021 to May 2022. Initial clinical-site recruitment was supplemented by private clinics, psychiatric practices, civic associations, and personal contact with patients and their supporters. The Scottish site used posters, flyers, and email invitations beginning January 2022, and later made use of third-party registers (eg, Scottish Health Research Register [SHARE] and Scottish Mental Health Research Network [SMHRN]) when initial recruitment channels proved insufficient. Recruitment ceased when minimum targets were achieved or no further participants were required.
Data Collection
Semistructured interviews were conducted by several trained researchers across participating clinical sites. All interviewers had previous training in psychology. Not all interviewers were coauthors of this manuscript; however, all received standardized training and followed a common interview protocol to ensure methodological consistency. The interviewers were supervised by (MW and TI), who also monitored adherence to the study guide and provided regular feedback during data collection.
Participants were interviewed either in person at the clinical site or via video call, depending on their preference. Interviews were recorded using an encrypted audio recorder with the written and verbal consent of the participants. The interviews were transcribed and coded in the local language at the sites where they were conducted.
Service users’ views on notifications, questions, user interface, functionality changes, data visualizations, sharing data with clinicians, and sharing data with others and any other topics related to the design of the DMMH prototype and its use that emerged from the interviews were analyzed. We developed interview scripts that were used for data collection across all 4 participating countries (). After informed consent, participants were informed about the purpose and how the DMMH is supposed to work; participants were shown prototypes of the MoMent app items and different visualizations of longitudinal patient data ( and ). Then participants were asked to share their feedback on the prototypes and how these could be implemented in their treatment. The interview guide comprised 23 questions, focusing on participants’ experiences with digital health tools, feedback on the DMMH prototype, perspectives on DMMH usability and its potential impact on the treatment, and potential barriers and facilitators of the use of such a tool. Additionally, vignettes with service user case examples were presented and discussed.
Data Processing
Preliminary processing of interview data to derive structured data items was performed using software designed for qualitative data analysis, namely MAXQDA (VERBI Software GmbH) and NVivo (Lumivero LLC).
Quotes used in this study were translated from the original language into English using DeepL software (DeepL SE) and checked by a native speaker for accuracy.
Data Analysis
The analysis followed a directed (top-down) qualitative content analysis approach [,], which starts with codes that are derived from a predefined theory (NASSS framework) []. The initial coding using anchor samples was done by local researchers speaking the native languages and throughout multiple sessions across countries, comparing understanding of individual codes, assurance has been achieved that all codes were interpreted in the same way. During this process, some codes were merged, omitted, or added, and the final codebook was created. This was followed by the main analysis. This first level of coding (using the NASSS framework) conducted by 2 coders per country represented the primary analysis reported elsewhere [], while we carried out a secondary, bottom-up analysis conducted by AK and NČ focusing on notifications, questions, user interface, functionality changes, data visualizations, sharing data with clinicians, sharing data with others, and any other topics related to the design of the tool and its use in general, and ESM data in particular. This was done by enriching the existing codes with new, more detailed subcodes that emerged from the analysis.
Techniques to Enhance Trustworthiness
To enhance the trustworthiness of the analysis, peer debriefing was carried out between 2 researchers (AK and NČ) to ensure consistency and credibility of interpretation. Emerging codes and themes were reviewed and discussed to challenge assumptions, refine interpretations, and ensure that findings accurately reflected participants’ perspectives. Consensus among team members was reached before finalizing the structure of categories.
Researcher Reflexivity
Some of the interviews were conducted by researchers who had previous clinical contact with the participants in the context of their routine treatment. This familiarity facilitated rapport and openness during the interviews but was also acknowledged as a potential source of bias. To minimize its influence, interviewers followed a standardized interview guide and adhered to reflexive practices throughout data collection.
Ethical Considerations
Applications to each country’s Ethics Review Board were coordinated using a joint protocol. Ethical approval was granted for all sites, in Belgium by Ethics Committee KU Leuven (S65990; January 11, 2022), in Germany by Ethics Committee II of Heidelberg University at the Mannheim Medical Faculty (633-21; September 24, 2021), in Scotland by South Central—Hampshire A Research Ethics Committee (REC reference: 21/SC/0397, IRAS project ID: 307153; December 23, 2021), and in Slovakia by Ethics Committee of the Faculty of Medicine, Comenius University and University Hospital Bratislava, Staré Mesto Hospital (115/2021; October 25, 2021) and Ethics Committee of the Faculty of Medicine, Pavol Jozef Safarik University in Kosice (1N/2022; January 27, 2022).
Participants received detailed written and oral information about the project as well as a comprehensive informed consent document.
The data collected during the interviews were pseudonymized and stored locally at the locations where the interviews took place. All subsequent data processing, including transfer to the IMMERSE project research database, was carried out using this pseudonymous identifier. The data are stored on a General Data Protection Regulation (GDPR)–compliant server at the University of Heidelberg’s computing center. The data elements derived after qualitative analysis do not contain any directly identifying data.
Participants were compensated for their time spent participating in the interview with €10 (US $11.60) in European Union countries and £10 (US $13.40) in Scotland.
Results
Participants
Of the 51 interviews, 12 participants met the narrower inclusion criteria for this study. The basic characteristics of the study sample are in .
| Participant ID | Sex | Age group (years) | Country | Employment status | Education | Diagnosis |
| P1 | Male | 31-40 | Slovakia | Employed | Secondary education | Substance use disorder |
| P2 | Male | 41-50 | Slovakia | Employed | Secondary education | Substance use disorder |
| P3 | Male | 31-40 | Slovakia | Employed | Graduate degree | Substance use disorder |
| P4 | Male | 31-40 | Slovakia | Not working | Vocational qualification | Substance use disorder |
| P5 | Female | 41-50 | Scotland | Not working | Primary | Schizophrenia |
| P6 | Nonbinary | 41-50 | Belgium | Employed | Graduate degree | Substance use disorder |
| P7 | Female | 41-50 | Belgium | Not working | Primary | Depression |
| P8 | Female | 41-50 | Belgium | Employed | Graduate degree | Substance use disorder and borderline personality disorder |
| P9 | Male | 18-30 | Germany | Not working | Vocational qualification | Schizophrenia |
| P10 | Female | 18-30 | Germany | Employed | Secondary education | Substance use disorder, ADHDa, and borderline personality disorder |
| P11 | Female | 18-30 | Germany | Employed | Secondary education | Substance use disorder, depression |
| P12 | Male | 31-40 | Germany | Not working | Primary | Substance use disorder, ADHD |
aADHD: attention-deficit hyperactivity disorder.
Main Findings
Seven categories were used from the original codebook and 8 subcategories were identified ().
| Categories | Subcategories |
| Notifications |
|
| Questions |
|
| User interface | —a |
| Functionality changes |
|
| Visualizations | — |
| Sharing data with clinicians | — |
| Sharing data with others | — |
aNot applicable.
Notifications: Number of Reminders Per Day
Participants who were employed considered 8-10 notifications per day to be excessive and suggested 3-5 notifications per day.
That does make sense, but it's also a lot. I mean, if I think about it, my typical day runs from around 7:30 a.m. to 10 p.m. Getting 10 notifications in that time is just a lot. ... I think realistically, something like 3 to 5 would make more sense.
[P10]
Those unemployed or hospitalized at the time considered 8-10 notifications per day feasible, even something that could help them structure the day. Also, even those who found 10 notifications too many at first would find this number acceptable if the questionnaire took a short time to complete.
I actually think it's good, so for me it's not too much. For others, it might be too much because- well, I'm currently unemployed, I have time, I can answer the questions. But there are people who work, and they can't really do that.
[P9]
Between 7 and 10 times a day? Ah yes, that seems like a lot, yes. And when then for example? Is that then, I'm just saying, every hour or what does that mean? Every two hours? ... [Interviewer: So that's actually, we usually count 2 minutes for a questionnaire.] Ah oh yes, then that's not a problem.
[P8]
It was also suggested to adapt the number of notifications to the patient’s condition and stage of treatment.
The app would have to be taught somehow, in some way, to be adaptable to a given rhythm, or I don't know, because the patient would then have to essentially subordinate to the app in their life. Maybe two levels, a level for someone who has to adapt because the information is needed at these intervals, and it occurs to me that someone who has less of a problem, so that's where it could be adapted to them [number of notifications].
[P2]
Questionnaire Availability Time
Participants indicated that postponing a questionnaire, so that it could be filled out at a later time point, would be desirable and facilitate completion. The time window is preferred to be from 15 minutes to 1 hour.
Well, postponing it would be acceptable, I would like that. For example, I cannot do it now because I have a lot of work to do, and I postpone it for an hour that I know I have to complete something, and within an hour one finds those 5 minutes to complete it.
[P4]
Questions
Participants appreciated the brevity and clarity of the questions used in the DMMH. They commented that it would be helpful if the situation they were in could be described more specifically, to capture the thoughts they had in the situation, and possibly what they did to cope with it.
The questions are actually clear in what they're about, and that's already a good thing.
[P12]
Yeah, if I'm tense because it can catch me in the moment, if I'm arguing with somebody, so if I'm feeling tense or how I'm actually reacting when I'm tense or something more specific. Something else I would add in there would be questions like how I handled that tension or how did I handle that situation where I felt bad and why did I feel good...something came up, something along those lines. Such lighter questions, whether I'm succeeding or failing to meet the daily plan and such questions. ... Watch my thoughts, but I don't know how to do that, because those feelings are probably one of the most important, but those thoughts are important too, I find it important to watch my thoughts too. So was I thinking of drugs now, or was I thinking of alcohol, an accomplice from the past. For us addicts, I think it's a recurring thing, that it's about the same thoughts, that I've walked down the street where I used to do drugs and it automatically comes back to me, so that's where you go back to that past - how many times a day I remembered it, or something like that.
[P4]
Adding Questions or Answer Options
Participants were informed that there were planned questions about substance use and craving. They suggested adding questions about different additional issues that were relevant to them, such as eating frequency and physical activity. Suggestions for better specification of context and activities were repeated.
But the eating, for example, I have a problem with that now. With gaining weight, and I would very much like to have a regular diet. To have maybe even a reminder, like my therapist said, like for 10 or brunch, because I'm totally skipping that and I'm doing it wrong, so that would be a great thing to have a reminder, but also to follow up on. For example, some sort of note to register that I've eaten lunch at that time, I'd welcome that.
[P2]
Maybe those options [answers about context], it seemed to me, what I only saw cursorily, that maybe there weren't enough of them, that maybe even more detail could have been broken down, that there was only the exterior, maybe even more precise, that where I was could have been there, at least a theme or something, but that's just kind of my idea. Yeah, it seems to me exactly that I would specify it more as to whether it's some kind of nature or I'm thinking...the city centre, the built-up area where there are more people or a nature, that what is the element that's affecting that person. Also outdoors, I also seek out different environments depending on my mood and what I need.
[P2]
Questionnaire Length
Some participants were willing to dedicate 5-10 minutes to one questionnaire but preferred shorter durations, for example, 2-3 minutes.
So, 5 to 10 minutes. Anything in between is perfectly okay. [Interviewer: Okay. Yeah wow, so the idea was that it's even just 3 to 5.] Which is probably even better for the majority of people who would use that, because if it takes too much time, then you're more willing not to do it and just answer “larifari” [sloppy], sort of, as long as it's quick.
[P11]
Two to three minutes, certainly no longer. But two minutes that goes at work. Ten minutes you shouldn't come off with.
[P6]
User Interface
There were repeated requests for a more colorful environment and clearer color differentiation of items from the background. Some participants preferred to see multiple questions, ideally all at once, rather than one at a time. Using an avatar was an acceptable option.
In theory, maybe you could make the background a bit more colorful, or at least the bubbles - just to make them stand out a bit more. You know, it's a bit monotone, I'd say.
[P12]
Yeah, the avatar's nice, I think it's nicer because it's taken in a playful way a little bit, so it's closer to people I think, it's closer to me personally, the avatar.
[P1]
Functionality Changes
In addition to a randomized schedule of questionnaires, participants also suggested a questionnaire that they could recall on demand, supplemented by the possibility of recording a note in the form of text. Two participants also suggested fixed morning, lunchtime, and evening questionnaires to fit in with their day’s schedule.
Or, if I have some kind of little ache or something, then I can click somewhere in the app on “Menu” and then kind of save “Notes” somewhere on the side or something like that. … You do have those note things normally on your phone, but you usually don’t use them, but, if you're already in the app, then maybe yeah. … Or you enter it in the calendar, and then you write a side note: “Had something happen today.” Or I don’t know. “Today this and that happened.” … you click on “Menu” and then you can still write a note, kind of in the background where the scale was - where it was bad, let’s say - if you had a bad day, then you could write something right there. Because, otherwise, you only kind of know what happened, and like this, you write on that day “Ah that really annoyed me” or “I managed it”, or whatever. Or something especially positive too. … you can just tell yourself: “Hey, I’m not doing so well right now, so I’ll just write something down.” Because, for example, if the rhythm is every two hours, but now it’s already after an hour or half an hour after something happened - something went wrong, and you’re just really like [feeling] “baaah” - then you’re not gonna wait one and a half hours until some kind of “bing” [notification prompt] comes again.
[P12]
You have a lot of other duties, I wouldn't mind for example during shopping, but I do manual work, I'm used to doing manual work and if I'm on the line and I run out two times on the app to fill it, the manager probably wouldn't praise me that what I'm doing all the time with that phone. Before work or before breakfast if I filled it out that how did I sleep let's say or how was my morning, at lunch it would ask me how my morning was, how am I feeling at the moment, in the afternoon or in the evening to do an inventory of the day, 3-4 times I would rate it that's just right.
[P4]
Interventions
The most commonly suggested addition to the app was the delivery of simple interventions informed by ESM data. Motivational quotes, grounding techniques, coping recommendations, crisis plans, or helpline contact were suggested.
Like there were just questions though, you might just be asking about that, but that maybe there would have been some solution to that as well. Or maybe something I would have suggested that something works for me, like I don't know... I'll give you an example, take five breaths, or be present, or I don't know.
[P3]
And maybe somewhere too, and this may be far fetched, but if things are really not going so well and they ask in the evening “What have you been up to?”, this and that, and you're still like “Yes, I'm really not feeling well” and that's certainly going to be the case with some people, yes, that you still have a number somewhere or something you can call. Even if it's just including the Suicide Hotline. That's maybe not ideal, but it can be somewhere [in the app]. Suppose it doesn't go well, what can I do? “You don't feel well. Here are some people you can reach” and then the basic instances and their number.
[P8]
Reminders
Participants also indicated that they would use the app as a tool to remind them of other issues related to treatment and healthy lifestyle, such as taking medication, proper nutrition, and fluid intake.
Yes, I think sleep and maybe food and drink as well, because yes, I have moments when I have very little structure, and I know that's kind of common here often with people that they don't eat 3 times a day.
[P8]
Customization
There was a request for the ability to customize the color and number of notifications.
It could be that way, everyone could customize it with their own colour, we all like different colours, we all like different things, so if everyone could customize it to their own liking, that would probably be the best in my opinion.
[P4]
Gamification
One participant also suggested gamification elements, such as earning points or some kind of praise, or awards in case of good compliance and goal achievement.
I downloaded this app called 'I'm Sober' - it shows you how long you've been sober, and after a few days this little rocket appears. You get kind of excited. And then you see, like, 'Okay, you've hit 100 days or 100 hours,' and this little character pops up and gives you a round of applause. It’s completely silly [laughs]. But somehow it really motivates me to keep using the app [laughs]. Just to see that little creature again.
[P10]
Visualizations
The visualizations presented met with positive reactions. Participants appreciated their potential to contribute to understanding the relationships between their experience and the context in which it takes place.
I would personally find that amazing because effectively that can make you think again of hey, uh that's where I feel unhappy, so that's where I'm wasting my time. But if I want to be happier, then I need to pay more attention. That's super in my mind.
[P7]
Sharing Data With Clinician
All participants found sharing data from the app with their clinician useful. Participants reported that, based on these data, the clinician can better understand their problems and help them more effectively.
I think it's most interesting with a therapist. Someone who has effective insight into and who knows the app very well, as well as the thinking behind it. I also think an app for the individual is important because, as I said, not everyone has [a therapist], but I think that yes, I now have more of the idea that it's actually better with a therapist who really knows the app inside out.
[P7]
Sharing Data With Others
Participants differed in their willingness to share data from the app with their loved ones. Those who state that they have close relationships with others and feel understood by those around them find sharing data useful. Conversely, those who feel misunderstood in relationships are also less willing to share this information.
I personally wouldn't have a problem with that, because I really learned in treatment that honesty is absolutely the number one priority, so also in communication with parents, which I'm trying to improve in my diagnosis, so it would actually be another argument, really indisputable information, it also just sets out how I feel subjectively, but I would take it that it would be some quality output that the parents could see, that I would show them, and they would perhaps then be able to better understand certain situations and conditions if they had that information.
[P2]
I can imagine that that is useful for some people, but I keep my family and friends very much out of this. My parents didn't know for two years that I was coming to therapy. So... the relationship that I have with the person... but I don't immediately have many people with whom I would share it [my app data]. But I hear from other patients that they do involve more people in their story [therapy process], so that can certainly be useful.
[P6]
Discussion
Principal Findings
This study examined the preferences of patients with problem substance use regarding the content, functionality, and appearance of the DMMH prototype, the use of which is planned as an adjunct to the usual treatment. The findings suggest that patients generally perceive the DMMH prototype positively. They provided several specific suggestions for content, functional and visual changes which are summarized in .
Patient-reported design and functionality preferences
- Up to 10 notifications per day are acceptable, depending on the daily routine and the patient’s condition.
- The questionnaire should be as short as possible.
- The questionnaire should also include open-text response options. These are mainly about circumstances, thoughts, and coping strategies.
- The time window to return to complete the questionnaire should be within 1 hour.
- Incorporate EMI in addition to monitoring.
- Use positive coloring and gamification.
- Visualize data in a simple and clear way.
- Enable data sharing with the clinician.
- Provide a voluntary option to share data with relatives.
- To allow individual customization in all the areas mentioned.
In general, multiple daily notifications were considered acceptable. Participants preferred a number and schedule of notifications that was tailored to their daily routine as well as their current treatment needs. A time window in which to return to the questionnaire was suggested, with 2 participants preferring a time of 1 hour. The acceptability of daily notifications is consistent with the findings of other authors where participants perceived it positively and as a feature that keeps them engaged with the app [,]. This could be specific to the group of patients with SUDs, as in studies with patients with other psychiatric diagnoses, 10 notifications per day was considered a rather burdensome amount [,]. In a research context, a higher frequency and number of notifications is tolerated if the questionnaire is short []. Also, being able to enter the questionnaire when the user unlocks the screen improves compliance [], which means that it may be advantageous to allow the patient to return to the questionnaire at a later time, but this comes at the cost of not capturing the moment when the notification arrived.
Participants suggested adding to the questions the possibility of recording circumstances, thoughts, or even coping strategies they used. Such a requirement was also a pressing concern in work that surveyed psychiatric patients’ attitudes toward a very similar tool informing the development of the DMMH []. Quantifying experience and context alone do not seem to capture all that patients consider important, and noting the specifics of a given situation could increase the potential to understand their patterns of behavior. Self-reflection and resulting insight in people recovering from SUDs are associated with higher treatment engagement, adherence, and abstinence maintenance [,]. Recurring suggestions for tracking and promoting healthy lifestyles are consistent with the general popularity of using mobile apps for these purposes [] and it is an important part of recovery from SUDs []. Therefore, it is important to consider this area when designing mHealth tools for individuals with SUDs.
Simple interventions, also called Ecological Momentary Interventions (EMIs), which should be proactively offered to patients based on ESM data, represent a shift from monitoring to intervention and may be useful in relapse prevention [,], although the effectiveness of specific kinds of EMIs requires further investigation []. If the tool offers such interventions, this contributes to its interactivity, which is a facilitator of user engagement [,].
Often, a more colorful design was requested, corresponding to a general preference for a more positive appearance and content for this type of tool [,]. Paradoxically, gamification was only suggested by 1 participant. The fact that this option was not mentioned by several participants may be because they were not asked specifically. However, when developing tools of this type, gamification elements should be offered to users as they increase engagement in their use []. Of course, whether to use them and, if so, what the gamification features should look like should be discussed with users.
Patients find data visualization useful, especially as a tool to better understand their patterns of behavior and experiences and the contexts in which they take place. Such perceptions of self-monitoring data visualizations are consistent with other studies [,]. Well-designed data visualizations can promote patient engagement and compliance, as well as increase the ability of both clinicians and patients to explore, interpret, and discuss data [,]. Patients usually best understand number lines and bar graphs, and clear color differentiation is effective in communicating risks, improving understanding and increasing confidence in interpretation []. Participants clearly preferred sharing data with their clinicians. They perceived this as an appropriate and valuable addition of information that could help to make treatment more effective. This agrees with the findings of Lyzwinski et al [], who found that patients in several studies perceived such sharing in a similar way. Willingness to share ESM data with loved ones varied. It depended mainly on the perceived quality of these relationships and a sense of being understood, which is also common when sharing information in other forms in mental health care settings [].
In terms of content, functionality, and appearance, there were often requests for customization and individualization options for the DMMH. This is consistent with other studies [,] and recommendations for increasing user engagement with such tools []. Nevertheless, clinicians do not make much use of personalization options, which may be due to time and organizational constraints. Therefore, when developing mHealth tools, it is important to strike a balance between the possibilities of individual personalization and the resulting demands on both the clinician and the patient []. Participatory inquiry followed by collaboration of important stakeholders, especially patients, clinicians, researchers, IT and user experience experts, increases the likelihood that the tool will be satisfactory and patients will be more willing to use it []. This willingness is enhanced by their early involvement in development [].
Implications for Future Research
The results of our study suggest several avenues for further research directions in the development and implementation of ESM-based mHealth tools for people with substance use problems. First, in collaboration with patients and clinicians, look for ways and opportunities to tailor the intensity of monitoring to the patient’s current needs as well as treatment goals. Specifically, consider the patient’s work-family balance and ability to respond to notifications. Also, consider the phase of treatment, where more intensive monitoring with a random schedule may be desirable in the initial phases, after relapse or when changing medication, but may not be necessary and may be burdensome for the patient at the time of remission and stabilization. In such a case, fixed schedule monitoring can be applied. Second, look for technical ways to effectively capture qualitative data to complement quantitative data in ESM protocols and to use it in a meaningful way for the benefit of patients, so that it is not too burdensome for them or for clinicians. Third, explore opportunities for effective linkage between ESM and EMI. This should include proactively offering an intervention based on ESM data, for example, when craving intensifies or intrapsychic tension increases.
The findings highlight the importance of tailoring ESM-based tools to patients’ preferences and treatment contexts. Within the broader IMMERSE project [], additional qualitative work was conducted to capture the perspectives of other stakeholders, including clinicians, people from the service user support network, and health care administrators involved in implementing such tools for use in general psychiatry setting. However, relatives of service users with problem substance use, clinicians specializing in this group of patients, and health care administrators for people with SUDs were represented only to a limited extent in the project. Future research should therefore ensure their adequate inclusion to better understand how ESM-based interventions can be integrated into clinical settings in a way that meets the needs of all stakeholders in the field of SUD treatment.
Limitations
Several limitations should be considered when interpreting the results of this study. First, the sample size is relatively small, which may reduce the generalizability of the results. Also, the relatively homogeneous sample in terms of age, with younger and older age groups missing, may have constrained the variability of perspectives. Moreover, the lack of data on race and ethnicity represents an important limitation. Cultural background may shape attitudes toward digital mental health tools, data sharing, and clinician-patient interaction, and these factors could not be examined in this study. Second, there is a risk of selection bias as it can be assumed that participants who are interested in digital technologies will agree to participate in such research and those who are sceptical will also be less willing to participate. Third, there is a risk of bias in terms of social desirability. Although the semistructured format and use of supplementary questions aimed to minimize this bias, participants knew that the interviewers were members of the wider team involved in the development of the DMMH and could therefore provide more positive feedback than they would otherwise have given. In addition, some interviews were conducted by researchers who had previous clinical contact with the participants.
Conclusions
Participants generally perceived this DMMH positively and expressed a willingness to undergo daily repeated monitoring, especially if one questionnaire takes as little time as possible to complete. This was the sole finding that distinguished individuals with problematic substance use from those with other mental health issues, as all other preferences were similar. Participants considered the possibility of noting down the specifics of situations in the form of open text to be important. Supplementing the monitoring with simple momentary interventions was welcome. Participants considered sharing the collected data with the clinician as beneficial for their collaboration and the success of the treatment. The possibility to adapt the content, the schedule of notifications, and the appearance of the tool to individual needs and preferences was considered important. The study concludes by highlighting the involvement of patients in the development of ESM-based mHealth tools for exploring the alignment of patients’ identified preferences with the realities of clinical practice.
Acknowledgments
The authors declare that generative artificial intelligence (GenAI) tools were used during the research and manuscript preparation process. Specifically, GenAI was used exclusively for translation purposes. The tool used was DeepL. All outputs generated by the GenAI tool were reviewed, verified, and edited by the authors, who take full responsibility for the content of the final manuscript. No GenAI tool was listed as an author or contributed to study design, data analysis, interpretation, or conclusions. All quotations included in this manuscript were translated from the original language into English using DeepL software and subsequently checked for accuracy by a native speaker of the respective language.
Funding
JRB was supported by a Marie Skłodowska-Curie fellowship (101063326). This project has received funding from the European Union’s Horizon 2020 research and innovation Program under grant agreement 945263 (IMMERSE). The funder had no involvement in the study design, data collection, analysis, interpretation, or the writing of the manuscript.
Data Availability
The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.
Conflicts of Interest
None declared.
Supplementary Materials 1. IMMERSE Service User Interview Guide.
PDF File (Adobe PDF File), 42 KBSupplementary Materials 2. IMMERSE MoMent app prototype.
MP4 File (MP4 Video), 3566 KBSupplementary Materials 3. IMMERSE Visualisation Examples.
PDF File (Adobe PDF File), 656 KBReferences
- Alexander K, Sanjuan P, Terplan M. The use of Ecological Momentary Assessment methods with people receiving medication for opioid use disorder: a systematic review. Curr Addict Rep. May 23, 2023;10(3):366-377. [CrossRef]
- Myin-Germeys I, Schick A, Ganslandt T, Hajdúk M, Heretik A, Van Hoyweghen I, et al. et al. The experience sampling methodology as a digital clinical tool for more person-centered mental health care: an implementation research agenda. Psychol Med. Aug 2024;54(11):2785-2793. [CrossRef] [Medline]
- Yim SJ, Lui LM, Lee Y, Rosenblat JD, Ragguett R, Park C, et al. The utility of smartphone-based, ecological momentary assessment for depressive symptoms. J Affect Disord. Sep 01, 2020;274:602-609. [CrossRef] [Medline]
- mHealth: new horizons for health through mobile technologies: second global survey on eHealth. WHO Global Observatory for eHealth. 2011. URL: https://iris.who.int/handle/10665/44607 [accessed 2025-01-15]
- Myin-Germeys I, Kasanova Z, Vaessen T, Vachon H, Kirtley O, Viechtbauer W, et al. Experience sampling methodology in mental health research: new insights and technical developments. World Psychiatry. Jun 2018;17(2):123-132. [FREE Full text] [CrossRef] [Medline]
- Shiffman S, Stone AA, Hufford MR. Ecological Momentary Assessment. Annu Rev Clin Psychol. 2008;4:1-32. [CrossRef] [Medline]
- Myin-Germeys I. Digital technology in psychiatry: towards the implementation of a true person-centered care in psychiatry? Eur Arch Psychiatry Clin Neurosci. Jun 2020;270(4):401-402. [FREE Full text] [CrossRef] [Medline]
- Myin-Germeys I. mHealth in psychiatry: A pathway to person-centered care. Psychiatry Res. Jan 2023;319:114978. [CrossRef] [Medline]
- Serre F, Gauld C, Lambert L, Baillet E, Beltran V, Daulouede J, et al. Predictors of substance use during treatment for addiction: a network analysis of ecological momentary assessment data. Addiction. Jan 2025;120(1):48-58. [CrossRef] [Medline]
- Piccirillo ML, Enkema MC, Foster KT. Using the experience sampling method to support clinical practice: an illustration with problematic cannabis use. Psychother Res. Feb 2024;34(2):241-260. [CrossRef] [Medline]
- Fernández-Miranda J, Pascual-Pastor F, Díaz-Fernández S, Navarro D, Manzanares J. Differences in substance use disorders and other mental disorders in mental health and addiction settings: sociodemographic, clinical, drug treatment, and gender differences. Int J Ment Health Addiction. Dec 22, 2022;22(4):2338-2356. [FREE Full text] [CrossRef]
- Flynn PM, Brown BS. Co-occurring disorders in substance abuse treatment: issues and prospects. J Subst Abuse Treat. Jan 2008;34(1):36-47. [FREE Full text] [CrossRef] [Medline]
- Serre F, Fatseas M, Swendsen J, Auriacombe M. Ecological momentary assessment in the investigation of craving and substance use in daily life: a systematic review. Drug Alcohol Depend. Mar 01, 2015;148:1-20. [CrossRef] [Medline]
- Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: commonalities and specificities across substances. Addict Behav. Aug 2018;83:123-129. [CrossRef] [Medline]
- Businelle M, Perski O, Hébert ET, Kendzor D. Mobile health interventions for substance use disorders. Annu Rev Clin Psychol. Jul 2024;20(1):49-76. [FREE Full text] [CrossRef] [Medline]
- Gustafson DH, McTavish FM, Chih M, Atwood AK, Johnson RA, Boyle MG, et al. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry. May 2014;71(5):566-572. [FREE Full text] [CrossRef] [Medline]
- Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, et al. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker. NPJ Digit Med. 2020;3:35. [FREE Full text] [CrossRef] [Medline]
- Paquette CE, Reese ED, Yi JY, Maccarone JM, Stewart ZJ, Daughters SB. Group behavioral activation with and without a smartphone app in intensive outpatient treatment for substance use disorder: a three-arm randomized controlled trial. Drug Alcohol Depend. Feb 01, 2023;243:109758. [FREE Full text] [CrossRef] [Medline]
- Greenhalgh T, Wherton J, Papoutsi C, Lynch J, Hughes G, A'Court C, et al. Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. J Med Internet Res. Nov 01, 2017;19(11):e367. [FREE Full text] [CrossRef] [Medline]
- Carreiro S, Newcomb M, Leach R, Ostrowski S, Boudreaux ED, Amante D. Current reporting of usability and impact of mHealth interventions for substance use disorder: a systematic review. Drug Alcohol Depend. Oct 01, 2020;215:108201. [FREE Full text] [CrossRef] [Medline]
- Lyzwinski LN, Elgendi M, Menon C. Users' acceptability and perceived efficacy of mHealth for opioid use disorder: scoping review. JMIR Mhealth Uhealth. Apr 11, 2024;12:e49751. [FREE Full text] [CrossRef] [Medline]
- Wyant K, Moshontz H, Ward S, Fronk G, Curtin JJ. Acceptability of personal sensing among people with alcohol use disorder: observational study. JMIR Mhealth Uhealth. 2023;11:e41833. [FREE Full text] [CrossRef]
- Helle AC, Freeman LK, Pellegrini AM, Wycoff AM, Winograd R, Trull TJ. Implementing an EMA burst design in community-engaged research: participant and researcher perspectives and recommendations. Am J Drug Alcohol Abuse. Jan 02, 2023;49(1):53-62. [FREE Full text] [CrossRef] [Medline]
- McChargue DE, Khan B, Phelps J, Duryea P, Tyler KA, Andrews A, et al. The feasibility of utilizing the open dynamic interaction network (ODIN) app to assess rEMA data across 30 days among those recovering from alcohol use disorders. Drug Alcohol Depend Rep. Mar 2025;14:100305. [FREE Full text] [CrossRef] [Medline]
- Michie S, Yardley L, West R, Patrick K, Greaves F. Developing and evaluating digital interventions to promote behavior change in health and health care: recommendations resulting from an international workshop. J Med Internet Res. Jun 29, 2017;19(6):e232. [FREE Full text] [CrossRef] [Medline]
- Szinay D, Jones A, Chadborn T, Brown J, Naughton F. Influences on the uptake of and engagement with health and well-being smartphone apps: systematic review. J Med Internet Res. May 29, 2020;22(5):e17572. [FREE Full text] [CrossRef] [Medline]
- Torous J, Wisniewski H, Bird B, Carpenter E, David G, Elejalde E, et al. Creating a digital health smartphone app and digital phenotyping platform for mental health and diverse healthcare needs: an interdisciplinary and collaborative approach. J Technol Behav Sci. Apr 27, 2019;4(2):73-85. [CrossRef]
- Rowland SP, Fitzgerald JE, Holme T, Powell J, McGregor A. What is the clinical value of mHealth for patients? NPJ Digit Med. 2020;3:4. [FREE Full text] [CrossRef] [Medline]
- Veldmeijer L, Terlouw G, Van Os J, Van Dijk O, Van 't Veer J, Boonstra N. The involvement of service users and people with lived experience in mental health care innovation through design: systematic review. JMIR Ment Health. Jul 25, 2023;10:e46590. [FREE Full text] [CrossRef] [Medline]
- Deniz-Garcia A, Fabelo H, Rodriguez-Almeida AJ, Zamora-Zamorano G, Castro-Fernandez M, Alberiche Ruano MDP, et al. WARIFA Consortium. Quality, usability, and effectiveness of mHealth apps and the role of artificial intelligence: current scenario and challenges. J Med Internet Res. May 04, 2023;25:e44030. [FREE Full text] [CrossRef] [Medline]
- Yardley L, Spring BJ, Riper H, Morrison LG, Crane DH, Curtis K, et al. Understanding and promoting effective engagement with digital behavior change interventions. Am J Prev Med. Nov 2016;51(5):833-842. [CrossRef] [Medline]
- Perski O, Baretta D, Blandford A, West R, Michie S. Engagement features judged by excessive drinkers as most important to include in smartphone applications for alcohol reduction: a mixed-methods study. Digit Health. 2018;4:2055207618785841. [FREE Full text] [CrossRef] [Medline]
- Sedotto RNM, Edwards AE, Dulin PL, King DK. Engagement with mHealth alcohol interventions: user perspectives on an app or chatbot-delivered program to reduce drinking. Healthcare (Basel). Jan 02, 2024;12(1):101. [FREE Full text] [CrossRef] [Medline]
- Bell L, Garnett C, Qian T, Perski O, Williamson E, Potts H. Engagement with a behavior change app for alcohol reduction: data visualization for longitudinal observational study. J Med Internet Res. Dec 11, 2020;22(12):e23369. [FREE Full text] [CrossRef] [Medline]
- Morgan DL. Paradigms lost and pragmatism regained. J Mix Methods Res. Jan 01, 2007;1(1):48-76. [CrossRef]
- Reininghaus U, Schwannauer M, Barne I, Beames JR, Bonnier RA, Brenner M, et al. et al. Strategies, processes, outcomes, and costs of implementing experience sampling-based monitoring in routine mental health care in four European countries: study protocol for the IMMERSE effectiveness-implementation study. BMC Psychiatry. Jun 24, 2024;24(1):465. [FREE Full text] [CrossRef] [Medline]
- Assarroudi A, Heshmati Nabavi F, Armat MR, Ebadi A, Vaismoradi M. Directed qualitative content analysis: the description and elaboration of its underpinning methods and data analysis process. J Res Nurs. Feb 2018;23(1):42-55. [FREE Full text] [CrossRef] [Medline]
- Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. Nov 2005;15(9):1277-1288. [CrossRef] [Medline]
- Ikegwuonu T, Kurilla A, Schulte-Strathaus JCC, de Thurah L, Marelli L, Hajdúk M, et al. Privacy and data sharing concerns using a mobile mental health recording app: a qualitative study exploring service users' views. OSF. 2023. URL: https://osf.io/dbm87/overview [accessed 2026-01-02]
- Giroux D, Bacon S, King DK, Dulin P, Gonzalez V. Examining perceptions of a smartphone-based intervention system for alcohol use disorders. Telemed J E Health. Oct 2014;20(10):923-929. [FREE Full text] [CrossRef] [Medline]
- Bos FM, von Klipstein L, Emerencia AC, Veermans E, Verhage T, Snippe E, et al. A web-based application for personalized Ecological Momentary Assessment in psychiatric care: user-centered development of the PETRA application. JMIR Ment Health. Aug 09, 2022;9(8):e36430. [FREE Full text] [CrossRef] [Medline]
- Weermeijer JDM, Wampers M, de Thurah L, Bonnier R, Piot M, Kuppens P, et al. Usability of the Experience Sampling Method in specialized mental health care: pilot evaluation study. JMIR Form Res. Nov 21, 2023;7:e48821. [FREE Full text] [CrossRef] [Medline]
- van Berkel N, Goncalves J, Lovén L, Ferreira D, Hosio S, Kostakos V. Effect of experience sampling schedules on response rate and recall accuracy of objective self-reports. Int J Hum-Comput Stud. May 2019;125:118-128. [CrossRef]
- Eisele G, Vachon H, Lafit G, Kuppens P, Houben M, Myin-Germeys I, et al. The effects of sampling frequency and questionnaire length on perceived burden, compliance, and careless responding in experience sampling data in a student population. Assessment. Mar 2022;29(2):136-151. [CrossRef] [Medline]
- Raftery D, Kelly PJ, Deane FP, Baker AL, Ingram I, Goh MC, et al. Insight in substance use disorder: a systematic review of the literature. Addict Behav. Dec 2020;111:106549. [CrossRef] [Medline]
- Stephenson GM, Zygouris N. Effects of self reflection on engagement in a 12-step addiction treatment programme: a linguistic analysis of diary entries. Addict Behav. Feb 2007;32(2):416-424. [CrossRef] [Medline]
- Milne-Ives M, Lam C, De Cock C, Van Velthoven MH, Meinert E. Mobile apps for health behavior change in physical activity, diet, drug and alcohol use, and mental health: systematic review. JMIR Mhealth Uhealth. Mar 18, 2020;8(3):e17046. [FREE Full text] [CrossRef] [Medline]
- Sugden SG, Merlo G, Manger S. Strengthening neuroplasticity in substance use recovery through lifestyle intervention. Am J Lifestyle Med. 2024;18(5):648-656. [CrossRef] [Medline]
- Scott CK, Dennis ML, Johnson KA, Grella CE. A randomized clinical trial of smartphone self-managed recovery support services. J Subst Abuse Treat. Oct 2020;117:108089. [FREE Full text] [CrossRef] [Medline]
- Perski O, Hébert ET, Naughton F, Hekler EB, Brown J, Businelle MS. Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review. Addiction. May 2022;117(5):1220-1241. [FREE Full text] [CrossRef] [Medline]
- Jakob R, Harperink S, Rudolf AM, Fleisch E, Haug S, Mair JL, et al. Factors influencing adherence to mHealth apps for prevention or management of noncommunicable diseases: systematic review. J Med Internet Res. May 25, 2022;24(5):e35371. [FREE Full text] [CrossRef] [Medline]
- Kim S. A systematic review on visualizations for self-generated health data for daily activities. Int J Environ Res Public Health. Sep 06, 2022;19(18):11166. [FREE Full text] [CrossRef] [Medline]
- Rickard N, Arjmand H, Bakker D, Seabrook E. Development of a mobile phone app to support self-monitoring of emotional well-being: a mental health digital innovation. JMIR Ment Health. Nov 23, 2016;3(4):e49. [FREE Full text] [CrossRef] [Medline]
- van Os J, Verhagen S, Marsman A, Peeters F, Bak M, Marcelis M, ESM-MERGE Investigators PhD, et al. The experience sampling method as an mHealth tool to support self-monitoring, self-insight, and personalized health care in clinical practice. Depress Anxiety. Jun 2017;34(6):481-493. [CrossRef] [Medline]
- Wu DTY, Xin C, Bindhu S, Xu C, Sachdeva J, Brown JL, et al. Clinician perspectives and design implications in using patient-generated health data to improve mental health practices: mixed methods study. JMIR Form Res. Aug 07, 2020;4(8):e18123. [FREE Full text] [CrossRef] [Medline]
- Turchioe MR, Myers A, Isaac S, Baik D, Grossman LV, Ancker JS, et al. A systematic review of patient-facing visualizations of personal health data. Appl Clin Inform. Aug 2019;10(4):751-770. [FREE Full text] [CrossRef] [Medline]
- Chatzidamianos G, Lobban F, Jones S. A qualitative analysis of relatives', health professionals' and service users' views on the involvement in care of relatives in bipolar disorder. BMC Psychiatry. Sep 24, 2015;15:228. [FREE Full text] [CrossRef] [Medline]
- Koumpouros Y. User-centric design methodology for mHealth apps: the PainApp paradigm for chronic pain. Technologies. Jan 31, 2022;10(1):25. [CrossRef]
- Ikwunne T, Hederman L, Wall PJ. DECENT: a sociotechnical approach for developing mobile health apps in underserved settings. Digit Health. 2023;9:20552076231203595. [FREE Full text] [CrossRef] [Medline]
Abbreviations
| DMMH: Digital Mobile Mental Health |
| EMI: Ecological Momentary Intervention |
| ESM: Experience Sampling Method |
| GDPR: General Data Protection Regulation |
| ICD-10: International Classification of Diseases, Tenth Revision |
| IMMERSE: Implementing Mobile Mental health Recording Strategy for Europe |
| mHealth: mobile health |
| NASSS: Non-Adoption, Abandonment, Scale-Up, Spread, and Sustainability |
| SHARE: Scottish Health Research Register |
| SMHRN: Scottish Mental Health Research Network |
| SUD: substance use disorder |
Edited by A Mavragani; submitted 23.Jun.2025; peer-reviewed by R Mertz, T Church; comments to author 05.Nov.2025; revised version received 14.Dec.2025; accepted 15.Dec.2025; published 15.Jan.2026.
Copyright©Adam Kurilla, Natália Čavojská, Theresa Ikegwuonu, Marta Nemčíková, Julia CC Schulte-Strathaus, Lotte Uyttebroek, Joanne R Beames, Dagmar Breznoščáková, Daniel Dančík, Michal Hajdúk, Anton Heretik, Ľubomíra Izáková, Zuzana Katreniaková, Inez Myin-Germeys, Ján Pečeňák, Ulrich Reininghaus, Anita Schick, Maria Wolters. Originally published in JMIR Formative Research (https://formative.jmir.org), 15.Jan.2026.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.

